Abstract
SummaryThe increased use of several different pharmaceutical agents has provided a positive impact to patients benefits. On the other hand, the ophthalmologist is seeing more patients with ocular side effects secondary to such agents. In particular, ocular toxicity induced by cancer chemotherapy, biologic agents and immunesuppressive drugs includes a broad spectrum of disorders, which reflect the peculiar physiological, anatomical and biochemical characteristics of the eye. The progresses achieved by the science in understanding ocular biostructure has allowed a better knowledge on ocular side effects. This achievement assists the ophthalmologist and other specialists to recognize them early and intervene before severe visual impairment occurs. A prompt intervention for the treatment‐related toxicities may also provide the opportunity for a minimization or resolution of an expected side effect. Therefore, ophthalmologist should examine patients for any therapy that can present potential ocular side effects, according to the type of used drug. The biostructure and pathophysiology of potential toxicity of different drugs will be reviewed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
